超低剖面INCRAFT装置在狭窄主动脉分叉中行腹主动脉瘤腔内修复的多中心回顾性研究
该多中心回顾性研究纳入127例使用INCRAFT装置行EVAR的患者,按主动脉分叉直径分为标准分叉组(>16 mm,96例)和狭窄分叉组(<16 mm,31例)。狭窄分叉组技术成功率为96.7%,与标准分叉组的98.9%相当(P=.1);两组1年生存率分别为96.7%和97.9%,无动脉瘤相关死亡,髂支一期通畅率分别为96.8%和98.9%(P=.088)。结论认为INCRAFT在狭窄主动脉分叉中行EVAR结果可接受。
要点
- 狭窄主动脉分叉(<16 mm)患者使用INCRAFT装置行EVAR的技术成功率与标准分叉患者相当。
- 狭窄分叉组1年生存率96.7%,无动脉瘤相关死亡,髂支一期通畅率96.8%。
- 狭窄分叉组中48.3%存在广泛钙化,29.9%存在环形重度钙化,需注意病例选择。
核心结论
- INCRAFT装置在狭窄主动脉分叉(<16 mm)中行EVAR显示出可接受的结果,技术成功率和髂支通畅率与标准分叉患者相当。
研究设计与样本
- 按主动脉分叉直径分为标准分叉组(>16 mm,96例)和狭窄分叉组(<16 mm,31例)。
主要发现
- 狭窄分叉组平均主动脉分叉直径为13.2 mm,标准分叉组为25.5 mm。
- 狭窄分叉组中21.8%存在局灶钙化(小于分叉周径三分之一),48.3%存在广泛钙化(分叉周径三分之二),29.9%存在环形重度钙化(分叉周径完全闭塞)。
- 技术成功率标准分叉组98.9%,狭窄分叉组96.7%(P=.1)。
- 髂支组件支架置入需求两组无显著差异(标准分叉组2.0% vs 狭窄分叉组3.2%;P=.07)。
- 1年生存率标准分叉组97.9%,狭窄分叉组96.7%,无动脉瘤相关死亡;平均随访时间分别为18.4个月和15.3个月。
临床怎么用
- 对于主动脉分叉狭窄(<16 mm)的腹主动脉瘤患者,可考虑使用超低剖面INCRAFT装置行EVAR。
- 术前应评估分叉钙化程度,狭窄分叉组中环形重度钙化比例较高,可能影响操作。
局限性
- 回顾性研究设计,样本量有限,狭窄分叉组仅31例。
- 随访时间较短,平均随访不足20个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although the long-term results of endovascular aortic repair (EVAR) with low-profile devices in patients with hostile iliac anatomies have been published, there are no reported results specifically for narrow aortic bifurcations (NAB). This study investigated the outcomes of EVAR with the INCRAFT device in NAB (<16 mm). METHODS: This multicenter retrospective study involved five vascular surgery centers. From November 2014 until June 2018, 127 patients were treated with the INCRAFT device. The patient population was divided into two groups based on aortic bifurcation diameter. They were designated as the (1) standard aortic bifurcation (SAB) group (>16 mm) and the (2) the NAB group (<16 mm). Primary end points were the differences between the two groups in terms of technical success, survival at 30 days, iliac limb patency, and reinterventions. RESULTS: The SAB group included 96 patients and the NAB group included 31 patients. The mean aortic bifurcation diameter was 25.5 mm in the SAB group and 13.2 mm in the NAB group. It is noteworthy that, in the NAB group, 21.8% of patients had aortic bifurcations with focal calcific lesions (less than one-third of the circumferential length of the bifurcation) and 48.3% showed extensive calcifications (two-thirds of the circumferential length of the bifurcation), for 29.9% of the patients in the NAB group the aortic bifurcation had a circumferential highly calcific lesion (complete occlusion of the circumferential length of the bifurcation). Technical success was 98.9% in the SAB group and 96.7% in the NAB group (P = .1). The need for iliac component stenting was not significantly different between the groups (SAB 2.0% vs NAB 3.2%; P = .07). The 1-year survival was 97.9% and 96.7% in the SAB and NAB groups, respectively, with no aneurysm-related mortality. The mean follow-up was 18.4 months and 15.3 months in the SAB and NAB groups, respectively. The iliac primary patency was 98.9 % in the SAB group and 96.8% in the NAB group (P = .088), and the primary assisted patency was 100% in both groups. CONCLUSIONS: EVAR with INCRAFT in NABs showed acceptable results. In this multicenter study, the results were comparable in terms of technical success and iliac patency rate between patients with SABs and NABs.
引用
- Orrico M, Ronchey S, Alberti V, et al. Outcomes of endovascular repair of abdominal aortic aneurysms in narrow aortic bifurcations using the ultra-low profile "INCRAFT" device: A retrospective multicenter study. J Vasc Surg. 2019. PMID: 31784279. doi:10.1016/j.jvs.2019.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。